UPDATE : Saturday, February 22, 2020
상단여백
HanAll, Daewoong unveil P3 topline results for dry eye treatment by Lee Han-soo 2020-01-16 15:46
Genome to conduct immunotherapy combo trial with Merck, Pfizer by Lee Han-soo 2020-01-16 14:47
GSK to target ovarian cancer, multiple myeloma, endometrial cancer by Kim Yun-mi 2020-01-16 14:10
Sweden prolongs financial support for IVI’s vaccine development by Lee Han-soo 2020-01-16 10:45
Pharmaceutical association lays out plans for 2020 by Lee Han-soo 2020-01-15 14:29
라인
AptaBio attending J.P. Morgan event for global collaboration by Shim Hyun-tai 2020-01-15 13:06
GC Pharma's US offshoot opens new plasma center by Shim Hyun-tai 2020-01-15 13:05
Jeil, Oncocross to discover new indications for stroke therapy by Lee Han-soo 2020-01-15 11:31
Will Steglatro prove SGLT-2 inhibitor’s cardiovascular benefits? by Kim Yun-mi 2020-01-14 15:28
Genexine becomes largest shareholder of GenNBio by Lee Han-soo 2020-01-14 11:11
라인
Daewoong, A2A to develop AI-based anticancer treatment by Lee Han-soo 2020-01-14 10:35
GSK shows meaningful response rate for treatment of multiple myeloma by Lee Han-soo 2020-01-13 17:48
Zejula widens indication as monotherapy for ovarian cancer by Kim Yun-mi 2020-01-13 16:25
Vivozon positive of Opiranserin’s efficacy despite failures to meet primary endpoint by Lee Han-soo 2020-01-13 16:22
Lilly secures atopic dermatitis drug through Dermira acquisition by Kim Yun-mi 2020-01-13 14:05
라인
Latecomer Bavencio improves overall survival in bladder cancer trial by Kim Yun-mi 2020-01-10 14:23
HLB gets UAE’s nod for joint company with local partner by Lee Han-soo 2020-01-08 16:31
Daewoong, Avacta to establish joint venture by Lee Han-soo 2020-01-08 12:25
Genexine licenses out immunosuppressant candidate to GenNBio by Lee Han-soo 2020-01-07 17:35
Mundipharma to market Biosolution's knee cartilage defect treatment by Lee Han-soo 2020-01-07 16:11
여백
여백
여백
Back to Top